• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,927.61 57.71
(0.11%)
Dow Jones
7,374.18 -5.04
(-0.07%)
Hang Seng
72,467.78 3,292.81
(4.76%)
Nikkei 225
10,536.79 75.16
(0.72%)
Forex
USD-INR
94.74 0.21
(0.22%)
EUR-INR
108.00 -0.19
(-0.17%)
GBP-INR
125.20 0.11
(0.09%)
JPY-INR
0.59 0.00
(0.26%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3622252
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
33.8
116353.96
EPS(TTM)
Face Value()
Div & Yield %
42.61
2
0.9
 

neueon corporation ltd
Hindustan Unilever consolidated net profit rises 21.43% in the March 2026 quarter
Apr 30,2026
Net profit of Hindustan Unilever rose 21.43% to Rs 2992.00 crore in the quarter ended March 2026 as against Rs 2464.00 crore during the previous quarter ended March 2025. Sales rose 8.15% to Rs 16207.00 crore in the quarter ended March 2026 as against Rs 14985.00 crore during the previous quarter ended March 2025.

For the full year,net profit rose 41.23% to Rs 15040.00 crore in the year ended March 2026 as against Rs 10649.00 crore during the previous year ended March 2025. Sales rose 5.27% to Rs 63763.00 crore in the year ended March 2026 as against Rs 60573.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales16207.0014985.00 8 63763.0060573.00 5
OPM %23.6724.14 -23.5924.26 -
PBDT4025.003850.00 5 15380.0015334.00 0
PBT3677.003532.00 4 14047.0014081.00 0
NP2992.002464.00 21 15040.0010649.00 41